📊 Q3 Earnings are here! Plan ahead with key data on upcoming stock reports - all in 1 placeSee list

Teladoc (TDOC) To Buy Best Doctors, Stock Hits New High

Published 06/19/2017, 10:17 PM
Updated 07/09/2023, 06:31 AM
ALGN
-
EDAP
-
INGN
-
TDOC
-

Teladoc Inc. (NYSE:TDOC) , a premier telehealth services provider, has inked a definitive agreement to acquire Best Doctors, a leader in medical consultation.

Teladoc has picked up Best Doctors given its wide network of more than 500,000 world-renowned experts spanning 450 medical specialties. Its presence in every major region of the world and strong analytic capabilities will enable Teladoc to provide superior service to its clients.

The news was well received by investors and the stock gained a good 5.29%, pushing it to a 52-week high of $35.85 on Jun 19.

The latest move is in sync with Teladoc’s inorganic growth strategy. The company made a number of acquisitions recently that have expanded its distribution capabilities and broadened its service offerings.

The most recent buyout of HealthiestYou in 2016 has enhanced Teladoc’s access to the market of small- and medium-sized employers. This underserved corner of the market segment offers Teladoc significant growth opportunities.

Apart from buyouts, Teladoc is busy forging partnerships and pacts to beef up its list of client.

Teladoc has been quite successful in acquiring and integrating companies, something that has accrued to its top line. The successful inorganic story is reflected in the company’s share price which has increased 176% over the last one year compared with the Zacks categorized Medical Services industry’s gain of 6.64%.

Teladoc is fast gaining ground in the burgeoning telehealth services industry in the U.S. Demand for the company’s services is being fueled by increasing health care costs following inefficient care, duplication of services, significant waste and extreme variation in access, cost and quality of care.

Teladoc fills in this gap by providing superior quality of care through a platform that caters to consumer demand and physician availability in real-time and in various modalities such as video, web, mobile and telephone. Moreover, the emergence of technology such as big data and analytics, cloud-based solutions, online video and mobile applications present the company with huge scope for growth.

Teladoc carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the medical sector are Align Technology, Inc. (NASDAQ:ALGN) , EDAP TMS S.A. (NASDAQ:EDAP) and Inogen Inc. (NASDAQ:INGN) . All three companies carry a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Align Technology, a medical dental supplies company, topped estimates in each of the last four quarters, with an average positive surprise of 59.23%.

Inogen, a medical instruments seller, beat estimates in each of the last four quarters, with an average positive surprise of 82.42%.

EDAP TMS surpassed estimates in two of the last four quarters, with an average positive surprise of 366.67%.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana. Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look. See the pot trades we're targeting>>



EDAP TMS S.A. (EDAP): Free Stock Analysis Report

Inogen, Inc (INGN): Free Stock Analysis Report

Align Technology, Inc. (ALGN): Free Stock Analysis Report

Teladoc, Inc. (TDOC): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.